Bottlenecks in Nucleic Acid Extraction: A Multi-Industrial approach with HiMedia Labs

An interview with Dr. Rajas Warke, Director of Molecular Biology and virology at HiMedia Labs.

Actuate’s pancreatic cancer therapy gains EMA OMPD

Elraglusib is aimed at treating pancreatic ductal adenocarcinoma. Credit: Jo Panuwat D/Shutterstock. Actuate Therapeutics has gained orphan medicinal product designation (OMPD) from the European Medicines

January 8, 2025

Delaying cord clamping could save lives of premature babies

Waiting for two minutes or longer to clamp the umbilical cord of a premature baby soon after birth could help reduce the risk of death,

November 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Bottlenecks in Nucleic Acid Extraction: A Multi-Industrial approach with HiMedia Labs

Actuate’s pancreatic cancer therapy gains EMA OMPD

Delaying cord clamping could save lives of premature babies

Body-positive content can broaden women’s concept of ideal body weight

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe